| (+)-pilocarpine | increases expression | ISO | RGD:69062 | 6480464 | Pilocarpine results in increased expression of CDKN1B mRNA | CTD | PMID:17971868 |
| (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CDKN1B mRNA | CTD | PMID:22079256 |
| (S)-nicotine | multiple interactions | EXP | | 6480464 | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide inhibits the reaction [Nicotine results in decreased expression of CDKN1B protein] | CTD | PMID:18805435 |
| (S)-nicotine | multiple interactions | EXP | | 6480464 | Nicotine results in increased expression of and results in increased stability of CDKN1B protein | CTD | PMID:15231866 |
| (S)-nicotine | decreases expression | EXP | | 6480464 | Nicotine results in decreased expression of CDKN1B protein | CTD | PMID:18805435 |
| 1,3-thiazolidine-2,4-dione | increases expression | EXP | | 6480464 | 2,4-thiazolidinedione results in increased expression of CDKN1B protein | CTD | PMID:15916743 |
| 1-naphthyl isothiocyanate | decreases expression | ISO | RGD:69062 | 6480464 | 1-Naphthylisothiocyanate results in decreased expression of CDKN1B mRNA | CTD | PMID:20551477 |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:69062 | 6480464 | Ethinyl Estradiol results in decreased expression of CDKN1B mRNA | CTD | PMID:17557909 |
| 17beta-estradiol | increases degradation | EXP | | 6480464 | Estradiol results in increased degradation of CDKN1B protein | CTD | PMID:17283133 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of CDKN1B protein | CTD | PMID:9705214 |
| 17beta-estradiol | increases expression | ISO | RGD:69116 | 6480464 | Estradiol results in increased expression of CDKN1B mRNA | CTD | PMID:17640349 |
| 17beta-estradiol | affects expression | ISO | RGD:69116 | 6480464 | Estradiol affects the expression of CDKN1B mRNA | CTD | PMID:15598610 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | Estradiol promotes the reaction [Medroxyprogesterone Acetate results in increased expression of CDKN1B protein]; more ... | CTD | PMID:17283133 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CDKN1B protein]; more ... | CTD | PMID:15157999 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CDKN1B protein]; more ... | CTD | PMID:22266097 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:69116 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CDKN1B mRNA | CTD | PMID:10398686 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:69062 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CDKN1B protein | CTD | PMID:14742689 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:69116 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CDKN1B protein | CTD | PMID:10398686 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of CDKN1B protein | CTD | PMID:9705214 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:69116 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CDKN1B mRNA | CTD | PMID:11804338 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:69116 | 6480464 | AHR affects the reaction [Tetrachlorodibenzodioxin results in increased expression of CDKN1B mRNA] | CTD | PMID:21995607 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:69116 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CDKN1B mRNA | CTD | PMID:11804338 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | affects localization | ISO | RGD:69116 | 6480464 | Tetrachlorodibenzodioxin affects the localization of CDKN1B protein | CTD | PMID:20805476 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects response to substance | ISO | RGD:69116 | 6480464 | CDKN1B protein affects the susceptibility to Tetrachlorodibenzodioxin | CTD | PMID:20805476 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:69116 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CDKN1B protein | CTD | PMID:18227101 PMID:20486776 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:69062 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CDKN1B mRNA | CTD | PMID:20566336 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:69116 | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene promotes the reaction [CDK2 protein binds to CCNA2 protein binds to CDKN1B protein]]; more ... | CTD | PMID:20637255 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:69116 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CDKN1B mRNA | CTD | PMID:11804338 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:69116 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CDKN1B mRNA | CTD | PMID:11804338 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:69116 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CDKN1B protein | CTD | PMID:20486776 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:69116 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CDKN1B mRNA | CTD | PMID:11879969 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:69116 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [Lipopolysaccharides affects the expression of CDKN1B protein]; more ... | CTD | PMID:12883080 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CDKN1B protein | CTD | PMID:15157999 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:69116 | 6480464 | [Tetrachlorodibenzodioxin co-treated with EGF protein] results in increased expression of CDKN1B protein; more ... | CTD | PMID:20486776 |
| 2-acetamidofluorene | multiple interactions | ISO | RGD:69062 | 6480464 | 2-Acetylaminofluorene promotes the reaction [Diethylnitrosamine results in decreased expression of CDKN1B protein]; more ... | CTD | PMID:17582756 |
| 2-amino-2-deoxy-D-glucopyranose | decreases expression | ISO | RGD:69062 | 6480464 | Glucosamine results in decreased expression of CDKN1B protein | CTD | PMID:15654767 |
| 2-methoxyethanol | increases expression | ISO | RGD:69062 | 6480464 | methyl cellosolve results in increased expression of CDKN1B mRNA | CTD | PMID:19643169 |
| 25-hydroxycholesterol | increases expression | ISO | RGD:69062 | 6480464 | 25-hydroxycholesterol results in increased expression of CDKN1B mRNA | CTD | PMID:17161435 |
| 3',5'-cyclic AMP | multiple interactions | EXP | | 6480464 | [Theophylline results in increased abundance of Cyclic AMP] which results in increased expression of CDKN1B protein | CTD | PMID:21693435 |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:69062 | 6480464 | [Pentoxifylline results in increased abundance of Cyclic AMP] which results in increased expression of CDKN1B protein; more ... | CTD | PMID:21693435 |
| 3,3',5-triiodo-L-thyronine | decreases expression | ISO | RGD:69062 | 6480464 | Triiodothyronine results in decreased expression of CDKN1B mRNA; more ... | CTD | PMID:16021636 |
| 3,3',5-triiodo-L-thyronine | decreases expression | ISO | RGD:69116 | 6480464 | Triiodothyronine results in decreased expression of CDKN1B protein | CTD | PMID:20638743 |
| 3,3',5-triiodo-L-thyronine | multiple interactions | ISO | RGD:69116 | 6480464 | THRB protein promotes the reaction [Triiodothyronine results in decreased expression of CDKN1B protein] | CTD | PMID:20638743 |
| 3,3',5-triiodo-L-thyronine | decreases expression | EXP | | 6480464 | Triiodothyronine results in decreased expression of CDKN1B protein | CTD | PMID:16021636 |
| 3,3'-diindolylmethane | increases expression | EXP | | 6480464 | 3,3'-diindolylmethane results in increased expression of CDKN1B protein | CTD | PMID:22290291 |
| 3-methylcholanthrene | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Methylcholanthrene results in increased expression of CDKN1B protein]; more ... | CTD | PMID:18022818 |
| 3-methylcholanthrene | increases response to substance | EXP | | 6480464 | CDKN1B protein results in increased susceptibility to Methylcholanthrene | CTD | PMID:18022818 |
| 3-methylcholanthrene | increases expression | EXP | | 6480464 | Methylcholanthrene results in increased expression of CDKN1B protein | CTD | PMID:18022818 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | decreases expression | EXP | | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of CDKN1B protein | CTD | PMID:18805435 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | multiple interactions | EXP | | 6480464 | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of CDKN1B protein] | CTD | PMID:18805435 |
| 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid | affects localization | EXP | | 6480464 | Am 580 affects the localization of CDKN1B protein | CTD | PMID:16618747 |
| 4-hydroxyphenyl retinamide | increases expression | EXP | | 6480464 | Fenretinide results in increased expression of CDKN1B protein | CTD | PMID:16270382 |
| 4-nitroquinoline N-oxide | decreases expression | ISO | RGD:69116 | 6480464 | 4-Nitroquinoline-1-oxide results in decreased expression of CDKN1B mRNA | CTD | PMID:22561872 |
| 4-vinylcyclohexene dioxide | affects expression | ISO | RGD:69116 | 6480464 | 4-vinyl-1-cyclohexene dioxide affects the expression of CDKN1B mRNA | CTD | PMID:20829426 |
| 5-aza-2'-deoxycytidine | affects expression | EXP | | 6480464 | [decitabine affects the expression of DNMT3B protein] which affects the expression of CDKN1B mRNA | CTD | PMID:18544619 |
| 5-aza-2'-deoxycytidine | multiple interactions | EXP | | 6480464 | [decitabine co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with Sirolimus] results in increased expression of CDKN1B mRNA | CTD | PMID:18622747 |
| 5-aza-2'-deoxycytidine | multiple interactions | EXP | | 6480464 | [decitabine co-treated with trichostatin A] results in increased expression of CDKN1B mRNA | CTD | PMID:17185465 |
| 5-fluorouracil | affects response to substance | EXP | | 6480464 | CDKN1B protein affects the susceptibility to Fluorouracil | CTD | PMID:17217824 |
| 5-fluorouracil | decreases expression | EXP | | 6480464 | Fluorouracil results in decreased expression of CDKN1B mRNA | CTD | PMID:18930000 |
| 9-cis-retinoic acid | multiple interactions | EXP | | 6480464 | seocalcitol inhibits the reaction [alitretinoin results in increased expression of CDKN1B protein] | CTD | PMID:16340750 |
| 9-cis-retinoic acid | increases expression | EXP | | 6480464 | alitretinoin results in increased expression of CDKN1B protein | CTD | PMID:16340750 |
| acetylsalicylic acid | multiple interactions | EXP | | 6480464 | [troglitazone co-treated with Aspirin] results in increased expression of CDKN1B protein | CTD | PMID:19908241 |
| acetylsalicylic acid | increases expression | ISO | RGD:69116 | 6480464 | Aspirin results in increased expression of CDKN1B protein | CTD | PMID:16880202 |
| acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of CDKN1B protein | CTD | PMID:20734998 |
| afimoxifene | multiple interactions | EXP | | 6480464 | [4-hydroxytamoxifen co-treated with lapatinib] results in increased expression of CDKN1B protein; more ... | CTD | PMID:15665275 |
| afimoxifene | increases expression | EXP | | 6480464 | 4-hydroxytamoxifen results in increased expression of CDKN1B protein; more ... | CTD | PMID:15665275 |
| afimoxifene | increases expression | ISO | RGD:69116 | 6480464 | 4-hydroxytamoxifen results in increased expression of CDKN1B mRNA; more ... | CTD | PMID:17640349 |
| aldehydo-D-glucosamine | decreases expression | ISO | RGD:69062 | 6480464 | Glucosamine results in decreased expression of CDKN1B protein | CTD | PMID:15654767 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | Staurosporine inhibits the reaction [Tretinoin results in increased phosphorylation of CDKN1B protein] | CTD | PMID:16618747 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of CDKN1B protein | CTD | PMID:11595732 more ... |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of CDKN1B protein | CTD | PMID:11595732 more ... |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of CDKN1B protein | CTD | PMID:16140954 more ... |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of CDKN1B protein | CTD | PMID:11595732 more ... |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of CDKN1B protein | CTD | PMID:15194426 more ... |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of CDKN1B protein | CTD | PMID:16140954 more ... |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | Thiophenes analog promotes the reaction [Tretinoin results in increased expression of CDKN1B protein] | CTD | PMID:16140954 |
| all-trans-retinoic acid | increases phosphorylation | ISO | RGD:69062 | 6480464 | Tretinoin results in increased phosphorylation of CDKN1B protein | CTD | PMID:16618747 |
| all-trans-retinoic acid | affects localization | ISO | RGD:69062 | 6480464 | Tretinoin affects the localization of CDKN1B protein | CTD | PMID:16618747 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | [Tretinoin results in increased ubiquitination of and results in increased degradation of SKP2 protein] which results in increased expression of CDKN1B protein | CTD | PMID:11595732 |
| all-trans-retinoic acid | increases phosphorylation | EXP | | 6480464 | Tretinoin results in increased phosphorylation of CDKN1B protein | CTD | PMID:16618747 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of CDKN1B protein | CTD | PMID:16140954 more ... |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of CDKN1B mRNA | CTD | PMID:17349212 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of CDKN1B | CTD | PMID:11519864 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | Tretinoin results in increased expression of and results in decreased degradation of CDKN1B protein | CTD | PMID:15695403 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | Tretinoin promotes the reaction [Butyrates results in increased expression of CDKN1B protein]; more ... | CTD | PMID:17431121 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | [Tretinoin co-treated with IFNG protein] results in increased expression of CDKN1B protein | CTD | PMID:17960384 |
| all-trans-retinoic acid | affects localization | EXP | | 6480464 | Tretinoin affects the localization of CDKN1B protein | CTD | PMID:16618747 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | Ro 41-5253 inhibits the reaction [Tretinoin promotes the reaction [Tetradecanoylphorbol Acetate results in decreased expression of CDKN1B protein]] | CTD | PMID:12421932 |
| ammonium chloride | affects expression | ISO | RGD:69062 | 6480464 | Ammonium Chloride affects the expression of CDKN1B mRNA | CTD | PMID:16483693 |
| arsenic atom | decreases expression | ISO | RGD:69116 | 6480464 | Arsenic results in decreased expression of CDKN1B mRNA | CTD | PMID:19654921 |
| atrazine | multiple interactions | EXP | | 6480464 | [Atrazine co-treated with Arsenates] results in increased expression of CDKN1B mRNA | CTD | PMID:18585445 |
| benzene | decreases expression | ISO | RGD:69116 | 6480464 | Benzene results in decreased expression of CDKN1B mRNA | CTD | PMID:20018183 |
| benzo[a]pyrene | decreases expression | ISO | RGD:69116 | 6480464 | Benzo(a)pyrene results in decreased expression of CDKN1B mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:69116 | 6480464 | AHR affects the reaction [Benzo(a)pyrene results in increased expression of CDKN1B mRNA]; more ... | CTD | PMID:21995607 |
| benzo[a]pyrene | increases expression | ISO | RGD:69116 | 6480464 | Benzo(a)pyrene results in increased expression of CDKN1B mRNA | CTD | PMID:21995607 |
| benzo[a]pyrene | decreases expression | ISO | RGD:69062 | 6480464 | Benzo(a)pyrene results in decreased expression of CDKN1B protein | CTD | PMID:17141280 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:69062 | 6480464 | AHR affects the reaction [Benzo(a)pyrene results in decreased expression of CDKN1B protein] | CTD | PMID:17141280 |
| berberine | increases expression | EXP | | 6480464 | Berberine results in increased expression of CDKN1B protein | CTD | PMID:16505103 |
| beta-D-glucosamine | decreases expression | ISO | RGD:69062 | 6480464 | Glucosamine results in decreased expression of CDKN1B protein | CTD | PMID:15654767 |
| beta-hexachlorocyclohexane | increases expression | ISO | RGD:69116 | 6480464 | beta-hexachlorocyclohexane results in increased expression of CDKN1B mRNA | CTD | PMID:17640349 |
| bicalutamide | increases expression | EXP | | 6480464 | bicalutamide results in increased expression of CDKN1B | CTD | PMID:11845989 |
| bis(2-chloroethyl) sulfide | decreases expression | ISO | RGD:69116 | 6480464 | Mustard Gas results in decreased expression of CDKN1B mRNA | CTD | PMID:15674843 |
| bisphenol A | increases expression | ISO | RGD:69062 | 6480464 | bisphenol A results in increased expression of CDKN1B protein | CTD | PMID:20692330 |
| brassinolide | decreases expression | EXP | | 6480464 | brassinolide results in decreased expression of CDKN1B protein | CTD | PMID:20833159 |
| bucladesine | increases expression | ISO | RGD:69062 | 6480464 | Bucladesine results in increased expression of CDKN1B protein | CTD | PMID:21693435 PMID:16718685 |
| bucladesine | increases expression | ISO | RGD:69062 | 6480464 | Bucladesine results in increased expression of CDKN1B protein | CTD | PMID:16718685 PMID:21693435 |
| budesonide | multiple interactions | ISO | RGD:69116 | 6480464 | Budesonide inhibits the reaction [vinyl carbamate results in decreased expression of CDKN1B protein] | CTD | PMID:12117777 |
| cadmium atom | increases expression | ISO | RGD:69062 | 6480464 | Cadmium results in increased expression of CDKN1B protein | CTD | PMID:16730872 |
| cadmium dichloride | increases expression | ISO | RGD:69062 | 6480464 | Cadmium Chloride results in increased expression of CDKN1B protein | CTD | PMID:16730872 |
| cadmium dichloride | multiple interactions | ISO | RGD:69116 | 6480464 | Cadmium Chloride inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CDKN1B protein] | CTD | PMID:11516527 PMID:12135628 |
| cadmium dichloride | multiple interactions | ISO | RGD:69116 | 6480464 | Cadmium Chloride promotes the reaction [Methylnitronitrosoguanidine results in decreased expression of CDKN1B mRNA] | CTD | PMID:12135628 |
| cadmium dichloride | decreases expression | ISO | RGD:69062 | 6480464 | Cadmium Chloride results in decreased expression of CDKN1B mRNA | CTD | PMID:18636176 |
| cadmium dichloride | multiple interactions | ISO | RGD:69116 | 6480464 | Cadmium Chloride inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CDKN1B protein] | CTD | PMID:12135628 PMID:11516527 |
| calciol | multiple interactions | EXP | | 6480464 | Cholecalciferol promotes the reaction [CDKN1B protein binds to CDK2 protein]; more ... | CTD | PMID:12907249 |
| calciol | increases expression | EXP | | 6480464 | Cholecalciferol results in increased expression of CDKN1B mRNA | CTD | PMID:12907249 |
| calcitriol | multiple interactions | EXP | | 6480464 | Calcitriol promotes the reaction [CDKN1B protein binds to CDK4 protein] | CTD | PMID:16322758 |
| calcitriol | increases expression | EXP | | 6480464 | Calcitriol results in increased expression of CDKN1B mRNA | CTD | PMID:9783903 PMID:11270487 |
| calcitriol | increases expression | EXP | | 6480464 | Calcitriol results in increased expression of CDKN1B protein | CTD | PMID:10825140 PMID:16039115 |
| calcitriol | increases expression | EXP | | 6480464 | Calcitriol results in increased expression of CDKN1B | CTD | PMID:11519864 |
| calcitriol | increases expression | EXP | | 6480464 | Calcitriol results in increased expression of CDKN1B protein | CTD | PMID:16039115 PMID:10825140 |
| calcitriol | increases expression | EXP | | 6480464 | Calcitriol results in increased expression of CDKN1B mRNA | CTD | PMID:11270487 PMID:9783903 |
| calcitriol | multiple interactions | EXP | | 6480464 | Calcitriol results in decreased phosphorylation of and results in decreased degradation of and results in increased stability of CDKN1B protein | CTD | PMID:12954644 |
| calcium dichloride | multiple interactions | ISO | RGD:69062 | 6480464 | Calcium Chloride inhibits the reaction [Azoxymethane results in decreased expression of CDKN1B protein] | CTD | PMID:12189186 |
| capsaicin | decreases expression | EXP | | 6480464 | Capsaicin results in decreased expression of CDKN1B protein | CTD | PMID:22226932 |
| capsaicin | increases expression | ISO | RGD:69116 | 6480464 | Capsaicin results in increased expression of CDKN1B | CTD | PMID:20069556 |
| capsaicin | increases expression | EXP | | 6480464 | Capsaicin results in increased expression of CDKN1B protein | CTD | PMID:19855437 |
| carbonyl sulfide | increases expression | ISO | RGD:69062 | 6480464 | carbonyl sulfide results in increased expression of CDKN1B mRNA | CTD | PMID:19395590 |
| cefaloridine | decreases expression | ISO | RGD:69062 | 6480464 | Cephaloridine results in decreased expression of CDKN1B mRNA | CTD | PMID:18500788 |
| celecoxib | multiple interactions | EXP | | 6480464 | [atorvastatin co-treated with celecoxib] results in increased expression of CDKN1B protein | CTD | PMID:18172863 |
| celecoxib | increases expression | EXP | | 6480464 | celecoxib results in increased expression of CDKN1B protein | CTD | PMID:19428934 PMID:21737646 |
| celecoxib | increases expression | EXP | | 6480464 | celecoxib results in increased expression of CDKN1B mRNA | CTD | PMID:19428934 |
| celecoxib | increases expression | EXP | | 6480464 | celecoxib results in increased expression of CDKN1B protein | CTD | PMID:21737646 PMID:19428934 |
| celecoxib | increases expression | EXP | | 6480464 | celecoxib results in increased expression of CDKN1B protein | CTD | PMID:21737646 |
| celecoxib | increases expression | ISO | RGD:69062 | 6480464 | celecoxib results in increased expression of CDKN1B protein | CTD | PMID:12960143 |
| celecoxib | multiple interactions | EXP | | 6480464 | celecoxib promotes the reaction [Valproic Acid results in increased expression of CDKN1B protein]; more ... | CTD | PMID:21737646 |
| chenodeoxycholic acid | affects localization | EXP | | 6480464 | Chenodeoxycholic Acid affects the localization of CDKN1B protein | CTD | PMID:20818264 |
| choline | multiple interactions | ISO | RGD:69116 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CDKN1B gene | CTD | PMID:20938992 |
| chromium(6+) | increases expression | ISO | RGD:69062 | 6480464 | chromium hexavalent ion results in increased expression of CDKN1B protein | CTD | PMID:21621607 |
| chromium(6+) | multiple interactions | EXP | | 6480464 | AKT1 protein affects the reaction [Vanadates inhibits the reaction [chromium hexavalent ion affects the localization of CDKN1B protein]]; more ... | CTD | PMID:19377290 |
| cisplatin | decreases response to substance | EXP | | 6480464 | CDKN1B results in decreased susceptibility to Cisplatin | CTD | PMID:21652059 |
| cisplatin | multiple interactions | EXP | | 6480464 | Cisplatin promotes the reaction [MIR630 mRNA results in increased expression of CDKN1B protein] | CTD | PMID:20145152 |
| cisplatin | decreases expression | ISO | RGD:69116 | 6480464 | Cisplatin results in decreased expression of CDKN1B mRNA | CTD | PMID:21151649 |
| cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of CDKN1B protein | CTD | PMID:21274007 |
| cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of CDKN1B mRNA | CTD | PMID:21092744 |
| cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin inhibits the reaction [[Sirolimus results in increased phosphorylation of AKT1 protein] which results in increased phosphorylation of FOXO3A protein]] which results in increased expression of CDKN1B protein; more ... | CTD | PMID:21092744 |
| cisplatin | multiple interactions | EXP | | 6480464 | Cisplatin promotes the reaction [bortezomib results in increased expression of CDKN1B protein] | CTD | PMID:19636294 |
| clobenpropit | multiple interactions | EXP | | 6480464 | [HRH4 protein results in increased susceptibility to clobenpropit] which results in increased expression of CDKN1B protein | CTD | PMID:22363581 |
| clofibric acid | multiple interactions | ISO | RGD:69062 | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CDKN1B mRNA | CTD | PMID:17602206 |
| clotrimazole | increases expression | EXP | | 6480464 | Clotrimazole results in increased expression of CDKN1B | CTD | PMID:20724915 |
| corticosterone | multiple interactions | ISO | RGD:69062 | 6480464 | Corticosterone promotes the reaction [CDKN1B protein binds to CDK4 protein] | CTD | PMID:12807724 |
| corticosterone | increases expression | ISO | RGD:69062 | 6480464 | Corticosterone results in increased expression of CDKN1B protein | CTD | PMID:12807724 |
| curcumin | increases expression | EXP | | 6480464 | Curcumin results in increased expression of CDKN1B mRNA | CTD | PMID:15713895 |
| curcumin | increases expression | EXP | | 6480464 | Curcumin results in increased expression of CDKN1B protein | CTD | PMID:18226269 PMID:18156803 |
| curcumin | increases expression | ISO | RGD:69062 | 6480464 | Curcumin results in increased expression of CDKN1B protein | CTD | PMID:17602960 |
| curcumin | multiple interactions | ISO | RGD:69062 | 6480464 | Buthionine Sulfoximine inhibits the reaction [Curcumin results in increased expression of CDKN1B protein] | CTD | PMID:17602960 |
| curcumin | multiple interactions | EXP | | 6480464 | TNFSF10 protein promotes the reaction [Curcumin results in increased expression of CDKN1B protein] | CTD | PMID:18226269 |
| curcumin | increases expression | ISO | RGD:69116 | 6480464 | Curcumin results in increased expression of CDKN1B protein | CTD | PMID:21594647 |
| curcumin | increases expression | EXP | | 6480464 | Curcumin results in increased expression of CDKN1B protein | CTD | PMID:18156803 PMID:18226269 |
| curcumin | decreases expression | EXP | | 6480464 | Curcumin results in decreased expression of CDKN1B protein | CTD | PMID:18593936 |
| cyclophosphamide | multiple interactions | EXP | | 6480464 | [Doxorubicin co-treated with Cyclophosphamide] affects the expression of CDKN1B mRNA | CTD | PMID:16322899 |
| cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of CDKN1B mRNA | CTD | PMID:20106945 |
| cyclosporin A | increases expression | ISO | RGD:69062 | 6480464 | Cyclosporine results in increased expression of CDKN1B mRNA | CTD | PMID:21865292 |
| dasatinib (anhydrous) | increases expression | EXP | | 6480464 | dasatinib results in increased expression of CDKN1B protein | CTD | PMID:16740687 PMID:20145167 |
| dasatinib (anhydrous) | increases expression | EXP | | 6480464 | dasatinib results in increased expression of CDKN1B protein | CTD | PMID:20145167 PMID:16740687 |
| daunorubicin | multiple interactions | ISO | RGD:69062 | 6480464 | fasudil affects the reaction [Daunorubicin affects the expression of CDKN1B mRNA] | CTD | PMID:20037814 |
| daunorubicin | affects expression | ISO | RGD:69062 | 6480464 | Daunorubicin affects the expression of CDKN1B mRNA | CTD | PMID:20037814 |
| Delta(9)-tetrahydrocannabinol | multiple interactions | EXP | | 6480464 | TES mutant form inhibits the reaction [Tetrahydrocannabinol results in increased expression of CDKN1B mRNA]; more ... | CTD | PMID:18454173 |
| Delta(9)-tetrahydrocannabinol | increases expression | EXP | | 6480464 | Tetrahydrocannabinol results in increased expression of CDKN1B mRNA | CTD | PMID:18454173 |
| dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of CDKN1B mRNA; more ... | CTD | PMID:19428934 |
| diarsenic trioxide | increases expression | EXP | | 6480464 | arsenic trioxide results in increased expression of CDKN1B gene | CTD | PMID:21544632 |
| diarsenic trioxide | increases expression | EXP | | 6480464 | arsenic trioxide results in increased expression of CDKN1B protein | CTD | PMID:20458559 PMID:20953137 |
| diarsenic trioxide | increases expression | EXP | | 6480464 | arsenic trioxide results in increased expression of CDKN1B mRNA | CTD | PMID:19236751 PMID:20458559 |
| diarsenic trioxide | increases expression | EXP | | 6480464 | arsenic trioxide results in increased expression of CDKN1B protein | CTD | PMID:20953137 PMID:20458559 |
| diarsenic trioxide | increases expression | EXP | | 6480464 | arsenic trioxide results in increased expression of CDKN1B mRNA | CTD | PMID:20458559 PMID:19236751 |
| diarsenic trioxide | decreases expression | EXP | | 6480464 | arsenic trioxide results in decreased expression of CDKN1B mRNA | CTD | PMID:19769630 |
| dibenzofuran | increases expression | ISO | RGD:69062 | 6480464 | dibenzofuran analog results in increased expression of CDKN1B protein; more ... | CTD | PMID:20566336 |
| dibenzofuran | multiple interactions | ISO | RGD:69062 | 6480464 | AHR protein promotes the reaction [dibenzofuran analog results in increased expression of CDKN1B mRNA] | CTD | PMID:20566336 |
| diethanolamine | decreases expression | ISO | RGD:69116 | 6480464 | diethanolamine results in decreased expression of CDKN1B mRNA | CTD | PMID:16014740 |
| diethanolamine | decreases expression | ISO | RGD:69062 | 6480464 | diethanolamine results in decreased expression of CDKN1B mRNA | CTD | PMID:16014740 |
| diethylstilbestrol | increases expression | ISO | RGD:69062 | 6480464 | Diethylstilbestrol results in increased expression of CDKN1B mRNA | CTD | PMID:17292805 |
| diethylstilbestrol | decreases expression | ISO | RGD:69062 | 6480464 | Diethylstilbestrol results in decreased expression of CDKN1B mRNA | CTD | PMID:21658437 |
| digitoxin | decreases expression | EXP | | 6480464 | Digitoxin analog results in decreased expression of CDKN1B protein; more ... | CTD | PMID:22037315 |
| dioxygen | increases expression | EXP | | 6480464 | Oxygen deficiency results in increased expression of CDKN1B mRNA | CTD | PMID:17914565 |
| disodium selenite | increases expression | ISO | RGD:69062 | 6480464 | Sodium Selenite results in increased expression of CDKN1B protein | CTD | PMID:19276161 |
| disulfiram | increases expression | EXP | | 6480464 | Disulfiram results in increased expression of CDKN1B protein | CTD | PMID:17079463 |
| divanadium pentaoxide | decreases expression | EXP | | 6480464 | vanadium pentoxide results in decreased expression of CDKN1B mRNA | CTD | PMID:17459161 |
| doxorubicin | affects expression | EXP | | 6480464 | Doxorubicin affects the expression of CDKN1B mRNA | CTD | PMID:16705698 |
| doxorubicin | affects expression | EXP | | 6480464 | Doxorubicin affects the expression of CDKN1B protein | CTD | PMID:16036217 PMID:17893511 |
| doxorubicin | multiple interactions | EXP | | 6480464 | wortmannin promotes the reaction [Doxorubicin results in increased expression of CDKN1B protein] | CTD | PMID:17935137 |
| doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of CDKN1B protein | CTD | PMID:17935137 |
| doxorubicin | affects expression | EXP | | 6480464 | Doxorubicin affects the expression of CDKN1B protein | CTD | PMID:17893511 PMID:16036217 |
| doxorubicin | multiple interactions | EXP | | 6480464 | [Doxorubicin co-treated with Cyclophosphamide] affects the expression of CDKN1B mRNA | CTD | PMID:16322899 |
| doxorubicin | decreases response to substance | EXP | | 6480464 | CDKN1B results in decreased susceptibility to Doxorubicin | CTD | PMID:21652059 |
| etoposide | increases expression | EXP | | 6480464 | Etoposide results in increased expression of CDKN1B protein | CTD | PMID:17935137 |
| etoposide | multiple interactions | EXP | | 6480464 | wortmannin promotes the reaction [Etoposide results in increased expression of CDKN1B protein] | CTD | PMID:17935137 |
| fenofibrate | multiple interactions | ISO | RGD:69062 | 6480464 | [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CDKN1B mRNA | CTD | PMID:18253720 |
| fenvalerate | multiple interactions | EXP | | 6480464 | CDKN1B protein inhibits the reaction [fenvalerate results in increased expression of CDK2 mRNA] | CTD | PMID:22850687 |
| fenvalerate | decreases response to substance | EXP | | 6480464 | CDKN1B protein results in decreased susceptibility to fenvalerate | CTD | PMID:22850687 |
| fenvalerate | decreases expression | EXP | | 6480464 | fenvalerate results in decreased expression of CDKN1B mRNA; more ... | CTD | PMID:22850687 |
| flavanone | increases expression | EXP | | 6480464 | flavanone results in increased expression of CDKN1B protein | CTD | PMID:22056764 |
| fluoxetine | increases expression | ISO | RGD:69116 | 6480464 | Fluoxetine results in increased expression of CDKN1B mRNA | CTD | PMID:21497159 |
| fluoxetine | affects expression | EXP | | 6480464 | Fluoxetine affects the expression of CDKN1B mRNA | CTD | PMID:18371935 |
| fluoxetine | multiple interactions | EXP | | 6480464 | [Fluoxetine results in decreased activity of CKS1B protein] which results in decreased degradation of CDKN1B protein | CTD | PMID:18371935 |
| folic acid | affects expression | EXP | | 6480464 | Folic Acid affects the expression of CDKN1B mRNA | CTD | PMID:16361273 |
| folic acid | multiple interactions | ISO | RGD:69116 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CDKN1B gene | CTD | PMID:20938992 |
| fulvestrant | multiple interactions | EXP | | 6480464 | fulvestrant inhibits the reaction [Estradiol results in increased degradation of CDKN1B protein] | CTD | PMID:17283133 |
| furan | increases expression | ISO | RGD:69062 | 6480464 | furan results in increased expression of CDKN1B mRNA | CTD | PMID:22079235 |
| gallic acid | increases expression | EXP | | 6480464 | Gallic Acid results in increased expression of CDKN1B protein | CTD | PMID:22245431 |
| gefitinib | multiple interactions | EXP | | 6480464 | gefitinib promotes the reaction [[zoledronic acid co-treated with 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide] results in decreased expression of CDKN1B protein] | CTD | PMID:16322342 |
| gefitinib | increases expression | EXP | | 6480464 | gefitinib results in increased expression of CDKN1B protein | CTD | PMID:17513607 PMID:16740687 |
| gefitinib | increases expression | EXP | | 6480464 | gefitinib results in increased expression of CDKN1B protein | CTD | PMID:16740687 PMID:17513607 |
| gefitinib | decreases expression | EXP | | 6480464 | gefitinib results in decreased expression of CDKN1B | CTD | PMID:14679152 |
| genistein | increases expression | EXP | | 6480464 | Genistein results in increased expression of CDKN1B protein | CTD | PMID:15829497 |
| genistein | increases expression | ISO | RGD:69116 | 6480464 | Genistein results in increased expression of CDKN1B mRNA | CTD | PMID:21048042 |
| GM1 ganglioside | decreases expression | ISO | RGD:69062 | 6480464 | G(M1) Ganglioside results in decreased expression of CDKN1B protein | CTD | PMID:15654767 |
| gold atom | multiple interactions | EXP | | 6480464 | [Gold binds to Dimethyldithiocarbamate] which results in increased expression of CDKN1B protein | CTD | PMID:17079469 |
| gold(0) | multiple interactions | EXP | | 6480464 | [Gold binds to Dimethyldithiocarbamate] which results in increased expression of CDKN1B protein | CTD | PMID:17079469 |
| hemin | decreases degradation | EXP | | 6480464 | Hemin results in decreased degradation of CDKN1B protein | CTD | PMID:17283133 |
| heparin | decreases expression | EXP | | 6480464 | Heparin analog results in decreased expression of CDKN1B protein | CTD | PMID:20201787 |
| heparin | increases expression | EXP | | 6480464 | Heparin analog results in increased expression of CDKN1B protein | CTD | PMID:18057711 |
| hesperetin | increases expression | EXP | | 6480464 | hesperetin results in increased expression of CDKN1B | CTD | PMID:17927510 |
| histamine | multiple interactions | EXP | | 6480464 | [HRH4 protein results in increased susceptibility to Histamine] which results in increased expression of CDKN1B protein | CTD | PMID:22363581 |
| hydralazine | multiple interactions | ISO | RGD:69062 | 6480464 | [troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of CDKN1B protein | CTD | PMID:11318962 |
| hydrogen chloride | affects localization | EXP | | 6480464 | Hydrochloric Acid affects the localization of CDKN1B protein | CTD | PMID:20818264 |
| hydroxyurea | increases expression | EXP | | 6480464 | Hydroxyurea results in increased expression of CDKN1B protein | CTD | PMID:10961388 |
| hydroxyurea | multiple interactions | EXP | | 6480464 | [Valproic Acid co-treated with Hydroxyurea] results in increased expression of CDKN1B mRNA | CTD | PMID:17653085 |
| imatinib | multiple interactions | ISO | RGD:69116 | 6480464 | imatinib promotes the reaction [bosutinib results in increased expression of CDKN1B protein]; more ... | CTD | PMID:17129604 |
| imatinib | multiple interactions | EXP | | 6480464 | [vorinostat co-treated with imatinib] results in increased expression of CDKN1B protein | CTD | PMID:12446442 |
| indole-3-methanol | increases expression | EXP | | 6480464 | indole-3-carbinol analog results in increased expression of CDKN1B protein | CTD | PMID:20570586 |
| indole-3-methanol | increases expression | EXP | | 6480464 | indole-3-carbinol results in increased expression of CDKN1B | CTD | PMID:16082211 |
| indomethacin | decreases expression | EXP | | 6480464 | Indomethacin results in decreased expression of CDKN1B mRNA | CTD | PMID:16984733 |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of CDKN1B protein | CTD | PMID:11260862 PMID:19428934 |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of CDKN1B protein | CTD | PMID:19428934 PMID:11260862 |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of CDKN1B mRNA | CTD | PMID:19428934 |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of CDKN1B protein | CTD | PMID:11260862 |
| kojic acid | multiple interactions | ISO | RGD:69062 | 6480464 | [Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CDKN1B mRNA; more ... | CTD | PMID:18544905 |
| L-ascorbic acid | multiple interactions | ISO | RGD:69062 | 6480464 | [Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CDKN1B mRNA | CTD | PMID:18544905 |
| L-cysteine | decreases expression | EXP | | 6480464 | Cysteine analog results in decreased expression of CDKN1B protein | CTD | PMID:15890017 |
| L-methionine | multiple interactions | ISO | RGD:69116 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CDKN1B gene | CTD | PMID:20938992 |
| L-mimosine | increases expression | EXP | | 6480464 | Mimosine results in increased expression of CDKN1B | CTD | PMID:10530763 |
| lactacystin | multiple interactions | EXP | | 6480464 | lactacystin inhibits the reaction [Estradiol results in increased degradation of CDKN1B protein] | CTD | PMID:17283133 |
| lactacystin | increases expression | EXP | | 6480464 | lactacystin results in increased expression of CDKN1B protein | CTD | PMID:12149143 |
| lamivudine | multiple interactions | EXP | | 6480464 | [Zidovudine co-treated with Lamivudine] results in decreased expression of CDKN1B mRNA | CTD | PMID:15784690 |
| lidocaine | affects expression | ISO | RGD:69116 | 6480464 | Lidocaine affects the expression of CDKN1B mRNA | CTD | PMID:18931217 |
| linalool | increases expression | EXP | | 6480464 | linalool results in increased expression of CDKN1B mRNA | CTD | PMID:19922762 |
| lithium atom | decreases expression | ISO | RGD:69062 | 6480464 | Lithium results in decreased expression of CDKN1B mRNA | CTD | PMID:15687245 |
| lithium atom | decreases expression | ISO | RGD:69062 | 6480464 | Lithium results in decreased expression of CDKN1B protein | CTD | PMID:18296634 PMID:15687245 |
| lithium atom | decreases expression | ISO | RGD:69062 | 6480464 | Lithium results in decreased expression of CDKN1B protein | CTD | PMID:15687245 PMID:18296634 |
| lithium chloride | decreases expression | EXP | | 6480464 | Lithium Chloride results in decreased expression of CDKN1B mRNA | CTD | PMID:17440966 |
| lovastatin | increases expression | EXP | | 6480464 | Lovastatin results in increased expression of CDKN1B protein | CTD | PMID:10502407 more ... |
| lovastatin | increases expression | EXP | | 6480464 | Lovastatin results in increased expression of CDKN1B protein | CTD | PMID:18034278 more ... |
| lovastatin | increases expression | EXP | | 6480464 | Lovastatin results in increased expression of CDKN1B protein | CTD | PMID:10502407 more ... |
| lovastatin | increases expression | EXP | | 6480464 | Lovastatin results in increased expression of CDKN1B protein | CTD | PMID:15118409 more ... |
| lovastatin | increases expression | EXP | | 6480464 | Lovastatin results in increased expression of CDKN1B protein | CTD | PMID:15118409 more ... |
| lovastatin | increases expression | ISO | RGD:69062 | 6480464 | Lovastatin results in increased expression of CDKN1B protein | CTD | PMID:9848777 |
| luteolin | increases expression | EXP | | 6480464 | Luteolin results in increased expression of CDKN1B protein | CTD | PMID:11322924 |
| LY294002 | increases expression | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of CDKN1B protein | CTD | PMID:17148679 PMID:11322924 |
| LY294002 | multiple interactions | EXP | | 6480464 | [resveratrol co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] results in increased expression of CDKN1B protein | CTD | PMID:21179458 |
| LY294002 | increases expression | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of CDKN1B protein | CTD | PMID:11322924 more ... |
| LY294002 | increases expression | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of CDKN1B protein | CTD | PMID:11322924 PMID:17148679 |
| LY294002 | increases expression | ISO | RGD:69116 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of CDKN1B protein | CTD | PMID:15601625 |
| LY294002 | multiple interactions | EXP | | 6480464 | [decitabine co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with Sirolimus] results in increased expression of CDKN1B mRNA | CTD | PMID:18622747 |
| medroxyprogesterone acetate | multiple interactions | EXP | | 6480464 | Estradiol promotes the reaction [Medroxyprogesterone Acetate results in increased expression of CDKN1B protein]; more ... | CTD | PMID:17283133 |
| medroxyprogesterone acetate | increases expression | EXP | | 6480464 | Medroxyprogesterone Acetate results in increased expression of CDKN1B protein | CTD | PMID:17283133 |
| menadione | multiple interactions | EXP | | 6480464 | SB 203580 inhibits the reaction [[sodium arsenite co-treated with Vitamin K 3] results in increased expression of CDKN1B protein] | CTD | PMID:19082730 |
| methotrexate | affects response to substance | EXP | | 6480464 | CDKN1B protein affects the susceptibility to Methotrexate | CTD | PMID:17217824 |
| methoxsalen | multiple interactions | EXP | | 6480464 | Methoxsalen inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CDKN1B protein] | CTD | PMID:15157999 |
| mifepristone | multiple interactions | EXP | | 6480464 | Mifepristone promotes the reaction [CDK2 protein binds to CDKN1B protein]; more ... | CTD | PMID:17545545 |
| mifepristone | multiple interactions | EXP | | 6480464 | Mifepristone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CDKN1B protein] | CTD | PMID:22266097 |
| mifepristone | multiple interactions | EXP | | 6480464 | Mifepristone inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Estradiol] results in increased expression of CDKN1B protein] | CTD | PMID:17283133 |
| mitomycin C | affects response to substance | EXP | | 6480464 | CDKN1B protein affects the susceptibility to Mitomycin | CTD | PMID:17217824 |
| mycophenolic acid | multiple interactions | EXP | | 6480464 | Mycophenolic Acid inhibits the reaction [IL2 protein results in decreased expression of CDKN1B protein] | CTD | PMID:12193749 |
| myo-inositol hexakisphosphate | decreases expression | EXP | | 6480464 | Phytic Acid results in decreased expression of CDKN1B protein | CTD | PMID:15868430 |
| N-acetyl-L-cysteine | increases expression | ISO | RGD:69062 | 6480464 | Acetylcysteine results in increased expression of CDKN1B protein | CTD | PMID:17602960 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Methylcholanthrene results in increased expression of CDKN1B protein]; more ... | CTD | PMID:18022818 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:69062 | 6480464 | Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in increased expression of CDKN1B protein] | CTD | PMID:17602960 |
| N-methyl-N'-nitro-N-nitrosoguanidine | multiple interactions | ISO | RGD:69116 | 6480464 | Cadmium Chloride inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CDKN1B protein] | CTD | PMID:12135628 PMID:11516527 |
| N-methyl-N'-nitro-N-nitrosoguanidine | multiple interactions | ISO | RGD:69116 | 6480464 | Cadmium Chloride inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CDKN1B protein] | CTD | PMID:11516527 PMID:12135628 |
| N-methyl-N'-nitro-N-nitrosoguanidine | decreases expression | ISO | RGD:69116 | 6480464 | Methylnitronitrosoguanidine results in decreased expression of CDKN1B mRNA | CTD | PMID:12135628 |
| N-methyl-N'-nitro-N-nitrosoguanidine | multiple interactions | ISO | RGD:69116 | 6480464 | Cadmium Chloride promotes the reaction [Methylnitronitrosoguanidine results in decreased expression of CDKN1B mRNA] | CTD | PMID:12135628 |
| N-methyl-N'-nitro-N-nitrosoguanidine | increases expression | ISO | RGD:69116 | 6480464 | Methylnitronitrosoguanidine results in increased expression of CDKN1B protein | CTD | PMID:11516527 PMID:12135628 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:69062 | 6480464 | 2-Acetylaminofluorene promotes the reaction [Diethylnitrosamine results in decreased expression of CDKN1B protein]; more ... | CTD | PMID:17582756 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:69062 | 6480464 | [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CDKN1B mRNA | CTD | PMID:18253720 |
| N-nitrosodiethylamine | decreases expression | ISO | RGD:69062 | 6480464 | Diethylnitrosamine results in decreased expression of CDKN1B protein | CTD | PMID:17582756 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:69062 | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CDKN1B mRNA | CTD | PMID:17602206 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:69062 | 6480464 | [Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CDKN1B mRNA; more ... | CTD | PMID:18544905 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:69116 | 6480464 | CDKN1B results in decreased susceptibility to [Diethylnitrosamine co-treated with Phenobarbital]; more ... | CTD | PMID:17620307 |
| naphthalene | decreases expression | ISO | RGD:69116 | 6480464 | naphthalene results in decreased expression of CDKN1B protein | CTD | PMID:18687389 |
| nilutamide | decreases expression | ISO | RGD:69116 | 6480464 | nilutamide results in decreased expression of CDKN1B protein | CTD | PMID:16616092 |
| nimesulide | increases expression | EXP | | 6480464 | nimesulide results in increased expression of CDKN1B | CTD | PMID:12717830 |
| nimesulide | increases expression | EXP | | 6480464 | nimesulide results in increased expression of CDKN1B protein | CTD | PMID:14567460 |
| nitroglycerin | increases expression | ISO | RGD:69062 | 6480464 | Nitroglycerin results in increased expression of CDKN1B mRNA | CTD | PMID:12102619 |
| NS-398 | increases expression | EXP | | 6480464 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in increased expression of CDKN1B protein | CTD | PMID:14567460 |
| oxaliplatin | increases expression | EXP | | 6480464 | oxaliplatin results in increased expression of CDKN1B protein | CTD | PMID:15204521 |
| paracetamol | affects expression | ISO | RGD:69062 | 6480464 | Acetaminophen affects the expression of CDKN1B mRNA | CTD | PMID:16701773 |
| phenobarbital | multiple interactions | ISO | RGD:69116 | 6480464 | CDKN1B results in decreased susceptibility to [Diethylnitrosamine co-treated with Phenobarbital]; more ... | CTD | PMID:17620307 |
| phenylephrine | increases expression | ISO | RGD:69062 | 6480464 | Phenylephrine results in increased expression of CDKN1B | CTD | PMID:15603588 |
| phorbol 13-acetate 12-myristate | decreases expression | EXP | | 6480464 | Tetradecanoylphorbol Acetate results in decreased expression of CDKN1B protein | CTD | PMID:12421932 |
| phorbol 13-acetate 12-myristate | multiple interactions | EXP | | 6480464 | Tretinoin promotes the reaction [Tetradecanoylphorbol Acetate results in decreased expression of CDKN1B protein]; more ... | CTD | PMID:12421932 |
| pioglitazone | multiple interactions | ISO | RGD:69062 | 6480464 | pioglitazone promotes the reaction [Diethylnitrosamine results in decreased expression of CDKN1B protein]; more ... | CTD | PMID:17582756 |
| piroxicam | multiple interactions | ISO | RGD:69062 | 6480464 | Piroxicam inhibits the reaction [Azoxymethane results in decreased expression of CDKN1B protein] | CTD | PMID:12189186 |
| prednisone | increases expression | EXP | | 6480464 | Prednisone results in increased expression of CDKN1B protein | CTD | PMID:15034294 |
| pterostilbene | increases expression | EXP | | 6480464 | pterostilbene results in increased expression of CDKN1B protein | CTD | PMID:23313376 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin promotes the reaction [CDKN1B protein binds to CDK2 protein] | CTD | PMID:11322924 |
| quercetin | increases expression | EXP | | 6480464 | Quercetin results in increased expression of CDKN1B protein | CTD | PMID:11322924 PMID:15829497 |
| quercetin | increases expression | EXP | | 6480464 | Quercetin results in increased expression of CDKN1B protein | CTD | PMID:15829497 PMID:11322924 |
| raloxifene | increases expression | EXP | | 6480464 | Raloxifene results in increased expression of CDKN1B protein | CTD | PMID:16536755 |
| reserpine | multiple interactions | ISO | RGD:69062 | 6480464 | [troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of CDKN1B protein | CTD | PMID:11318962 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of CDKN1B protein | CTD | PMID:15829497 more ... |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Methylcholanthrene results in increased expression of CDKN1B protein] | CTD | PMID:18022818 |
| resveratrol | multiple interactions | EXP | | 6480464 | FOXO1 protein affects the reaction [resveratrol results in increased expression of CDKN1B protein]; more ... | CTD | PMID:21179458 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of CDKN1B protein | CTD | PMID:15829497 more ... |
| resveratrol | increases expression | ISO | RGD:69116 | 6480464 | resveratrol results in increased expression of CDKN1B protein | CTD | PMID:21980390 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of CDKN1B mRNA | CTD | PMID:16761963 PMID:18089832 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of CDKN1B protein | CTD | PMID:15829497 more ... |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of CDKN1B protein | CTD | PMID:15829497 more ... |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of CDKN1B protein | CTD | PMID:17050787 more ... |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of CDKN1B protein | CTD | PMID:15829497 more ... |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of CDKN1B protein | CTD | PMID:17088997 more ... |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of CDKN1B protein | CTD | PMID:16761963 more ... |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of CDKN1B protein | CTD | PMID:15829497 more ... |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of CDKN1B protein | CTD | PMID:16761963 more ... |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol promotes the reaction [FOXO3 protein binds to CDKN1B promoter] | CTD | PMID:17513867 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of CDKN1B mRNA | CTD | PMID:16761963 |
| rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of CDKN1B protein | CTD | PMID:20210794 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | ISO | RGD:69062 | 6480464 | Buthionine Sulfoximine inhibits the reaction [Curcumin results in increased expression of CDKN1B protein]; more ... | CTD | PMID:17602960 |
| Se-methyl-L-selenocysteine | increases expression | ISO | RGD:69062 | 6480464 | selenomethylselenocysteine results in increased expression of CDKN1B protein | CTD | PMID:19276161 PMID:11396176 |
| Se-methyl-L-selenocysteine | increases expression | ISO | RGD:69062 | 6480464 | selenomethylselenocysteine results in increased expression of CDKN1B protein | CTD | PMID:11396176 PMID:19276161 |
| Se-methylselenocysteine | increases expression | ISO | RGD:69062 | 6480464 | selenomethylselenocysteine results in increased expression of CDKN1B protein | CTD | PMID:19276161 PMID:11396176 |
| Se-methylselenocysteine | increases expression | ISO | RGD:69062 | 6480464 | selenomethylselenocysteine results in increased expression of CDKN1B protein | CTD | PMID:11396176 PMID:19276161 |
| simvastatin | multiple interactions | EXP | | 6480464 | [Simvastatin results in decreased degradation of CDKN1B protein] which results in decreased activity of CDK2 protein | CTD | PMID:17928568 |
| simvastatin | increases expression | EXP | | 6480464 | Simvastatin results in increased expression of CDKN1B protein | CTD | PMID:17428261 PMID:20878096 |
| simvastatin | increases expression | EXP | | 6480464 | Simvastatin results in increased expression of CDKN1B protein | CTD | PMID:20878096 PMID:17428261 |
| simvastatin | increases expression | ISO | RGD:69062 | 6480464 | Simvastatin results in increased expression of CDKN1B mRNA | CTD | PMID:12963647 |
| simvastatin | increases expression | ISO | RGD:69062 | 6480464 | Simvastatin results in increased expression of CDKN1B protein | CTD | PMID:18804536 |
| simvastatin | increases expression | EXP | | 6480464 | Simvastatin results in increased expression of CDKN1B protein | CTD | PMID:20878096 |
| simvastatin | increases expression | EXP | | 6480464 | Simvastatin results in increased expression of CDKN1B mRNA | CTD | PMID:18337644 |
| sirolimus | multiple interactions | EXP | | 6480464 | [Cisplatin inhibits the reaction [[Sirolimus results in increased phosphorylation of AKT1 protein] which results in increased phosphorylation of FOXO3A protein]] which results in increased expression of CDKN1B protein; more ... | CTD | PMID:21092744 |
| sirolimus | increases expression | EXP | | 6480464 | Sirolimus results in increased expression of CDKN1B protein | CTD | PMID:21092744 more ... |
| sirolimus | increases expression | EXP | | 6480464 | Sirolimus results in increased expression of CDKN1B protein | CTD | PMID:15070696 more ... |
| sirolimus | increases expression | EXP | | 6480464 | Sirolimus results in increased expression of CDKN1B protein | CTD | PMID:16455087 more ... |
| sirolimus | multiple interactions | ISO | RGD:69062 | 6480464 | Sirolimus inhibits the reaction [BTC protein affects the localization of CDKN1B protein]; more ... | CTD | PMID:19105244 |
| sirolimus | multiple interactions | ISO | RGD:69116 | 6480464 | [TGFB1 protein co-treated with Sirolimus] promotes the reaction [CDK2 protein binds to CDKN1B protein] | CTD | PMID:12417722 |
| sirolimus | multiple interactions | ISO | RGD:69116 | 6480464 | [Sirolimus co-treated with TGFB1 protein] promotes the reaction [CDKN1B protein binds to CDK2 protein]; more ... | CTD | PMID:14979923 |
| sirolimus | multiple interactions | EXP | | 6480464 | [TGFB1 protein co-treated with Sirolimus] promotes the reaction [CDK2 protein binds to CDKN1B protein] | CTD | PMID:12417722 |
| sirolimus | increases expression | EXP | | 6480464 | Sirolimus results in increased expression of CDKN1B protein | CTD | PMID:15070696 more ... |
| sirolimus | decreases degradation | EXP | | 6480464 | Sirolimus results in decreased degradation of CDKN1B protein | CTD | PMID:12565877 |
| sirolimus | multiple interactions | EXP | | 6480464 | [decitabine co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with Sirolimus] results in increased expression of CDKN1B mRNA | CTD | PMID:18622747 |
| sirolimus | multiple interactions | EXP | | 6480464 | [Sirolimus co-treated with TGFB1 protein] affects the localization of CDKN1B protein | CTD | PMID:14979923 |
| staurosporine | multiple interactions | EXP | | 6480464 | Staurosporine inhibits the reaction [Tretinoin results in increased phosphorylation of CDKN1B protein] | CTD | PMID:16618747 |
| sulindac | multiple interactions | ISO | RGD:69062 | 6480464 | Sulindac inhibits the reaction [Azoxymethane results in decreased expression of CDKN1B protein] | CTD | PMID:12189186 |
| tacrolimus hydrate | increases expression | ISO | RGD:69062 | 6480464 | Tacrolimus results in increased expression of CDKN1B mRNA | CTD | PMID:21865292 |
| tamoxifen | multiple interactions | EXP | | 6480464 | [Tamoxifen co-treated with FTI 277] promotes the reaction [CDKN1B protein binds to [CCNE1 protein binds to CDK2 protein]] | CTD | PMID:12866041 |
| tamoxifen | increases activity | EXP | | 6480464 | Tamoxifen results in increased activity of CDKN1B protein | CTD | PMID:15665275 |
| tamoxifen | multiple interactions | EXP | | 6480464 | [Tamoxifen co-treated with tipifarnib] results in increased expression of CDKN1B protein | CTD | PMID:17876043 |
| temozolomide | multiple interactions | EXP | | 6480464 | [temozolomide co-treated with O(6)-benzylguanine] results in decreased expression of CDKN1B protein | CTD | PMID:20980775 |
| temozolomide | multiple interactions | ISO | RGD:69116 | 6480464 | [temozolomide co-treated with O(6)-benzylguanine] results in decreased expression of CDKN1B protein | CTD | PMID:20980775 |
| terazosin | increases expression | EXP | | 6480464 | Terazosin results in increased expression of CDKN1B protein | CTD | PMID:12883741 |
| testosterone | decreases expression | ISO | RGD:69116 | 6480464 | Testosterone results in decreased expression of CDKN1B mRNA | CTD | PMID:15788153 |
| tetrachloromethane | decreases expression | ISO | RGD:69116 | 6480464 | Carbon Tetrachloride results in decreased expression of CDKN1B protein | CTD | PMID:12759355 |
| tetrachloromethane | multiple interactions | ISO | RGD:69116 | 6480464 | CDKN1B protein affects the reaction [Carbon Tetrachloride results in increased expression of CDKN1A protein] | CTD | PMID:12759355 |
| theophylline | multiple interactions | EXP | | 6480464 | [Theophylline results in increased abundance of Cyclic AMP] which results in increased expression of CDKN1B protein | CTD | PMID:21693435 |
| theophylline | multiple interactions | ISO | RGD:69062 | 6480464 | [Theophylline results in increased abundance of Cyclic AMP] which results in increased expression of CDKN1B protein; more ... | CTD | PMID:21693435 |
| thioacetamide | affects localization | ISO | RGD:69062 | 6480464 | Thioacetamide affects the localization of CDKN1B protein | CTD | PMID:22659510 |
| tolbutamide | increases expression | ISO | RGD:69062 | 6480464 | Tolbutamide results in increased expression of CDKN1B protein | CTD | PMID:16718685 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of CDKN1B protein | CTD | PMID:15829497 more ... |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Methylcholanthrene results in increased expression of CDKN1B protein] | CTD | PMID:18022818 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | FOXO1 protein affects the reaction [resveratrol results in increased expression of CDKN1B protein]; more ... | CTD | PMID:21179458 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of CDKN1B protein | CTD | PMID:15829497 more ... |
| trans-resveratrol | increases expression | ISO | RGD:69116 | 6480464 | resveratrol results in increased expression of CDKN1B protein | CTD | PMID:21980390 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of CDKN1B mRNA | CTD | PMID:16761963 PMID:18089832 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of CDKN1B protein | CTD | PMID:15829497 more ... |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of CDKN1B protein | CTD | PMID:15829497 more ... |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of CDKN1B protein | CTD | PMID:17050787 more ... |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of CDKN1B protein | CTD | PMID:15829497 more ... |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of CDKN1B protein | CTD | PMID:17088997 more ... |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of CDKN1B protein | CTD | PMID:16761963 more ... |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of CDKN1B protein | CTD | PMID:15829497 more ... |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of CDKN1B protein | CTD | PMID:16761963 more ... |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol promotes the reaction [FOXO3 protein binds to CDKN1B promoter] | CTD | PMID:17513867 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of CDKN1B mRNA | CTD | PMID:16761963 |
| trichostatin A | multiple interactions | EXP | | 6480464 | [decitabine co-treated with trichostatin A] results in increased expression of CDKN1B mRNA | CTD | PMID:17185465 |
| trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of CDKN1B protein; more ... | CTD | PMID:17431121 |
| trichostatin A | affects expression | EXP | | 6480464 | [trichostatin A affects the expression of DNMT3B protein] which affects the expression of CDKN1B mRNA | CTD | PMID:18544619 |
| trichostatin A | multiple interactions | EXP | | 6480464 | Tretinoin promotes the reaction [trichostatin A results in increased expression of CDKN1B protein]; more ... | CTD | PMID:17431121 |
| troglitazone | multiple interactions | EXP | | 6480464 | [troglitazone co-treated with Aspirin] results in increased expression of CDKN1B protein | CTD | PMID:19908241 |
| troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of CDKN1B protein | CTD | PMID:11343236 more ... |
| troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of CDKN1B protein | CTD | PMID:11343236 more ... |
| troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of CDKN1B protein | CTD | PMID:12149143 more ... |
| troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of CDKN1B protein | CTD | PMID:17143939 more ... |
| troglitazone | multiple interactions | EXP | | 6480464 | [troglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of CDKN1B protein | CTD | PMID:11034103 |
| troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of CDKN1B protein | CTD | PMID:12149143 more ... |
| troglitazone | affects response to substance | EXP | | 6480464 | CDKN1B protein affects the susceptibility to troglitazone | CTD | PMID:11034103 |
| troglitazone | decreases expression | ISO | RGD:69062 | 6480464 | troglitazone results in decreased expression of CDKN1B protein | CTD | PMID:11318962 |
| troglitazone | multiple interactions | ISO | RGD:69062 | 6480464 | [troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of CDKN1B protein | CTD | PMID:11318962 |
| troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of CDKN1B protein | CTD | PMID:16374840 more ... |
| troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of CDKN1B mRNA; more ... | CTD | PMID:12680223 |
| troglitazone | multiple interactions | EXP | | 6480464 | [troglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of and results in increased ubiquitination of CDKN1B protein; more ... | CTD | PMID:14618613 |
| troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of CDKN1B protein | CTD | PMID:12824901 more ... |
| troglitazone | multiple interactions | EXP | | 6480464 | troglitazone promotes the reaction [CDKN1B protein binds to CDK2 protein] | CTD | PMID:12717389 |
| troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of CDKN1B mRNA | CTD | PMID:17143939 |
| urethane | decreases expression | ISO | RGD:69116 | 6480464 | Urethane results in decreased expression of CDKN1B mRNA | CTD | PMID:12117781 |
| valproic acid | multiple interactions | EXP | | 6480464 | celecoxib promotes the reaction [Valproic Acid results in increased expression of CDKN1B protein]; more ... | CTD | PMID:21737646 |
| valproic acid | increases expression | ISO | RGD:69116 | 6480464 | Valproic Acid results in increased expression of CDKN1B protein | CTD | PMID:21708246 |
| valproic acid | multiple interactions | EXP | | 6480464 | [Valproic Acid co-treated with Hydroxyurea] results in increased expression of CDKN1B mRNA | CTD | PMID:17653085 |
| valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of CDKN1B protein | CTD | PMID:21737646 |
| valsartan | multiple interactions | EXP | | 6480464 | valsartan inhibits the reaction [AGT protein results in decreased expression of CDKN1B mRNA] | CTD | PMID:19225232 |
| vinyl carbamate | multiple interactions | ISO | RGD:69116 | 6480464 | Budesonide inhibits the reaction [vinyl carbamate results in decreased expression of CDKN1B protein] | CTD | PMID:12117777 |
| vinyl carbamate | decreases expression | ISO | RGD:69116 | 6480464 | vinyl carbamate results in decreased expression of CDKN1B protein | CTD | PMID:12117777 |
| wortmannin | multiple interactions | EXP | | 6480464 | wortmannin promotes the reaction [Etoposide results in increased expression of CDKN1B protein]; more ... | CTD | PMID:17935137 |
| wortmannin | increases expression | ISO | RGD:69116 | 6480464 | wortmannin results in increased expression of CDKN1B protein | CTD | PMID:17129604 |
| wortmannin | multiple interactions | ISO | RGD:69116 | 6480464 | imatinib promotes the reaction [wortmannin results in increased expression of CDKN1B protein] | CTD | PMID:17129604 |
| zidovudine | multiple interactions | EXP | | 6480464 | [Zidovudine co-treated with Lamivudine] results in decreased expression of CDKN1B mRNA | CTD | PMID:15784690 |
| zinc dichloride | decreases expression | EXP | | 6480464 | zinc chloride results in decreased expression of CDKN1B mRNA | CTD | PMID:21540303 |
| zoledronic acid | multiple interactions | EXP | | 6480464 | [zoledronic acid co-treated with 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide] results in decreased expression of CDKN1B protein; more ... | CTD | PMID:16322342 |
| zoledronic acid | multiple interactions | EXP | | 6480464 | zoledronic acid promotes the reaction [CYR61 protein affects the expression of CDKN1B protein] | CTD | PMID:19530242 |